Status:
UNKNOWN
The Regulatory Role of Immune Response in Oral Lichen Planus
Lead Sponsor:
Peking University Third Hospital
Conditions:
Oral Lichen Planus
Eligibility:
All Genders
18+ years
Brief Summary
Oral lichen planus (OLP) is a common chronic inflammatory disease of Oral mucosa. The pathogenesis of OLP is not clear, and there is no effective method to cure it. In vitro, previous studies have sho...
Eligibility Criteria
Inclusion
- patients with oral lichen planus
- male or female patients older than 18 years of age
- patients willing to participate with signed informed consent.
Exclusion
- pregnant or lactating
- had serious systemic diseases of the heart, lung, liver, and kidney, or had tumors
- were unwilling to participate in the experiment.
Key Trial Info
Start Date :
September 7 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2025
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT05997173
Start Date
September 7 2020
End Date
February 1 2025
Last Update
August 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking University Third Hospital
Beijing, China